Abstract Background and Aims At present, the world population problem is increasingly serious, and the impact of environmental pollution on the health of pregnant women and fetuses is a global research focus. Among them, micro(nano)plastics (MNPs), as an emerging pollutant, has been confirmed by several animal experiments and in vitro human cell experiments to have biotoxic effects. Recent studies have shown that MNPs are found in human placenta, amniotic fluid, meconium, and other samples, but there is still a lack of direct evidence that MNPs can enter and bioaccumulate in the fetus. Method To initially explore the actual situation of neonatal exposure to MNPs, this study collected umbilical cord blood samples and postnatal urine samples from 6 healthy fetuses in Chengdu, Sichuan, China, and used pyrolysis-gas chromatography/mass spectrometry (Py-GC/MS) and laser direct infrared spectroscopy (LDIR) to detect and analyze MNPs in samples. Results With an average abundance of 81.15 (40.71) μg/g, MNPs were found in 6 umbilical cord blood samples by Py-GC/MS. Polyethylene (PE), polyvinyl chloride (PVC), polystyrene (PS) and polyamide 66 (PA66), 4 different types of MNPs were found, with PE content being the highest among them. By using LDIR, MNPs were found in 5 umbilical cord blood samples, with an average abundance of 17.39 (18.91) particles/g. Three different types of MNPs were found, they are acrylates (ACR), polyethylene terephthalate (PET) and polypropylene (PP). MNPs particles were detected in 6 urine samples by PY-GC/MS, and the average abundance was 8.42 (4.70) μg/g. Two kinds of MNPs, PE and PVC, were detected, and the content of PE was higher. Conclusion The findings demonstrated that the contents and types of MNPs in umbilical cord blood samples were higher than those in urine samples. The levels of MNPs were correlated with the living habits of pregnant mothers, such as the frequency of ordering take-out food. In this study, through the detection of MNPs in umbilical cord blood and neonatal urine samples, we found the direct evidence of MNPs in the fetus for the first time, further confirmed that MNPs can enter the urine through renal metabolism, preliminarily explored the exposure and bioaccumulation effect of MNPs in the fetus, and analyzed the possible risks and related factors of exposure of MNPs during pregnancy, which provided a theoretical basis for in-depth study of the health impact of MNPs on pregnant women and fetuses.
Read full abstract